Health Care › Services-Hospitals
EHC Stock Price Correlated With Encompass Health Financials
External Links ⌄
Income Statement
Cash Flow
Balance Sheet
EHC Income Statement
Enable JavaScript and reload
Revenue, Net:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
EHC Cash Flow
Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:
EHC Balance Sheet
Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:
COMPANY PROFILE
Basis of Presentation Encompass Health Corporation, incorporated in Delaware in 1984, including its subsidiaries, is a leading provider of post-acute healthcare services, offering both facility-based and home-based patient services in 42 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. We manage our operations and disclose financial information using two reportable segments: (1) inpatient rehabilitation and (2) home health and hospice. See also Note 11, Segment Reporting .
On December 9, 2020, we announced a formal process to explore strategic alternatives for our home health and hospice business. As a result of this process, we expect to spin off our home health and hospice business to form an independent, publicly traded company on July 1, 2022, subject to customary conditions, including the effectiveness of a Form 10 registration statement, regulatory approvals and receipt of a favorable IRS private letter ruling. On January 19, 2022, we announced the home health and hospice business would be rebranded and operate under the name Enhabit Home Health & Hospice. The rebranding of agency locations began in mid-April 2022 and is expected to be largely completed by the effective date of the spin off.
The accompanying unaudited condensed consolidated financial statements of Encompass Health Corporation and Subsidiaries should be read in conjunction with the consolidated financial statements and accompanying notes contained in Encompass Health’s Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on February 25, 2022 (the “2021 Form 10‑K”). The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim financial information. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been omitted in these interim statements, as allowed by such SEC rules and regulations. The condensed consolidated balance sheet as of December 31, 2021 has been derived from audited financial statements, but it does not include all disclosures required by GAAP. However, we believe the disclosures are adequate to make the information presented not misleading.
The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed consolidated financial statements recognize all adjustments of a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented. Certain prior-year amounts have been reclassified to conform to the current year presentation.
Net Operating Revenues —
Our Net operating revenues disaggregated by payor source and segment are as follows (in millions):
Inpatient Rehabilitation Home Health and Hospice Consolidated Three Months Ended March 31, Three Months Ended March 31, Three Months Ended March 31, 2022 2021 2022 2021 2022 2021 Medicare $ 689.9 $ 614.5 $ 217.4 $ 223.9 $ 907.3 $ 838.4 Medicare Advantage
156.0 158.4 34.5 28.0 190.5 186.4 Managed care
131.5 112.2 18.8 14.3 150.3 126.5 Medicaid 41.7 39.0 3.5 3.8 45.2 42.8 Other third-party payors 10.1 12.1 — — 10.1 12.1 Workers’ compensation 6.1 5.7 0.1 0.1 6.2 5.8 Patients 5.2 4.9 — 0.2 5.2 5.1 Other income 18.8 13.1 — 0.2 18.8 13.3 Total $ 1,059.3 $ 959.9 $ 274.3 $ 270.5 $ 1,333.6 $ 1,230.4
See Note 1, Summary of Significant Accounting Policies , to the consolidated financial statements accompanying the 2021 Form 10-K for our policy related to Net operating revenues .
Recently Adopted Accounting Pronouncements —
We do not believe any recently issued, but not yet effective, accounting standards will have a material effect on
On December 9, 2020, we announced a formal process to explore strategic alternatives for our home health and hospice business. As a result of this process, we expect to spin off our home health and hospice business to form an independent, publicly traded company on July 1, 2022, subject to customary conditions, including the effectiveness of a Form 10 registration statement, regulatory approvals and receipt of a favorable IRS private letter ruling. On January 19, 2022, we announced the home health and hospice business would be rebranded and operate under the name Enhabit Home Health & Hospice. The rebranding of agency locations began in mid-April 2022 and is expected to be largely completed by the effective date of the spin off.
The accompanying unaudited condensed consolidated financial statements of Encompass Health Corporation and Subsidiaries should be read in conjunction with the consolidated financial statements and accompanying notes contained in Encompass Health’s Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on February 25, 2022 (the “2021 Form 10‑K”). The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim financial information. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been omitted in these interim statements, as allowed by such SEC rules and regulations. The condensed consolidated balance sheet as of December 31, 2021 has been derived from audited financial statements, but it does not include all disclosures required by GAAP. However, we believe the disclosures are adequate to make the information presented not misleading.
The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed consolidated financial statements recognize all adjustments of a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented. Certain prior-year amounts have been reclassified to conform to the current year presentation.
Net Operating Revenues —
Our Net operating revenues disaggregated by payor source and segment are as follows (in millions):
Inpatient Rehabilitation Home Health and Hospice Consolidated Three Months Ended March 31, Three Months Ended March 31, Three Months Ended March 31, 2022 2021 2022 2021 2022 2021 Medicare $ 689.9 $ 614.5 $ 217.4 $ 223.9 $ 907.3 $ 838.4 Medicare Advantage
156.0 158.4 34.5 28.0 190.5 186.4 Managed care
131.5 112.2 18.8 14.3 150.3 126.5 Medicaid 41.7 39.0 3.5 3.8 45.2 42.8 Other third-party payors 10.1 12.1 — — 10.1 12.1 Workers’ compensation 6.1 5.7 0.1 0.1 6.2 5.8 Patients 5.2 4.9 — 0.2 5.2 5.1 Other income 18.8 13.1 — 0.2 18.8 13.3 Total $ 1,059.3 $ 959.9 $ 274.3 $ 270.5 $ 1,333.6 $ 1,230.4
See Note 1, Summary of Significant Accounting Policies , to the consolidated financial statements accompanying the 2021 Form 10-K for our policy related to Net operating revenues .
Recently Adopted Accounting Pronouncements —
We do not believe any recently issued, but not yet effective, accounting standards will have a material effect on
Free historical financial statements for Encompass Health Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 55 quarters since 2011. Compare with EHC stock chart to see long term trends.
Data imported from Encompass Health Corp SEC filings. Check original filings before making any investment decision.